Lateral flow assays (LFAs) are paper-based point-of-care (POC) diagnostic tools that are
widely used because of their low cost, ease of use, and rapid format. Unfortunately …

Cancer is one of the main causes of mortality and morbidity worldwide. However, its early
non-invasive detection via quantification of appropriate biomarkers can significantly reduce …

Lateral flow assays (LFAs) provide some of the most attractive point-of-care instruments for
broad applications with simple, rapid, user-friendly, and cost-effective characteristics …

Due to the recent pandemic caused by coronavirus disease 2019 (COVID-19), the lateral
flow immunoassay used for its rapid antigen test is more popular than ever before. However …

Lateral flow assay (LFA) has become one of the most widely used point-of-care diagnostic
methods due to its simplicity and low cost. While easy to use, LFA suffers from its low …

Lateral flow assays (LFAs) are a popular method for quick and affordable diagnostic testing
because they are easy to use, portable, and user-friendly. However, LFA design has always …

A lateral flow assay (LFA) platform is a powerful tool for point-of-care testing (POCT),
especially for self-testing. Although the LFA platform provides a simple and disposable tool …

Dot-filtration immunoassays (DFIAs) are powerful tools for simple and rapid field detection;
however, the relatively poor sensitivity and accuracy of DFIAs limit their use in practical …

Abstract Point-of-care (POC) technology reduces the time required for diagnosis at a
reduced cost to facilitate early treatment, continuous monitoring, and prevention of fatal …

Protein biomarkers are useful for disease diagnosis. Identification thereof using in vitro
diagnostics such as lateral flow immunoassays (LFIAs) has attracted considerable attention …